Viveve Medical Stock Cash And Equivalents
| VIVEDelisted Stock | USD 0.1 0.0005 0.53% |
Viveve Medical fundamentals help investors to digest information that contributes to Viveve Medical's financial success or failures. It also enables traders to predict the movement of Viveve Pink Sheet. The fundamental analysis module provides a way to measure Viveve Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Viveve Medical pink sheet.
Viveve |
Viveve Medical Company Cash And Equivalents Analysis
Viveve Medical's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current Viveve Medical Cash And Equivalents | 9.43 M |
Most of Viveve Medical's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Viveve Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
CompetitionIn accordance with the recently published financial statements, Viveve Medical has 9.43 M in Cash And Equivalents. This is 98.85% lower than that of the Health Care Equipment & Supplies sector and 98.31% lower than that of the Health Care industry. The cash and equivalents for all United States stocks is 99.65% higher than that of the company.
Viveve Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Viveve Medical's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Viveve Medical could also be used in its relative valuation, which is a method of valuing Viveve Medical by comparing valuation metrics of similar companies.Viveve Medical is currently under evaluation in cash and equivalents category among its peers.
Viveve Fundamentals
| Return On Equity | -2.11 | ||||
| Return On Asset | -0.62 | ||||
| Operating Margin | (3.10) % | ||||
| Current Valuation | 4.26 M | ||||
| Shares Outstanding | 10.72 M | ||||
| Shares Owned By Institutions | 5.21 % | ||||
| Number Of Shares Shorted | 374.24 K | ||||
| Price To Earning | (2.59) X | ||||
| Price To Book | 3.62 X | ||||
| Price To Sales | 0.66 X | ||||
| Revenue | 6.43 M | ||||
| Gross Profit | 620 K | ||||
| EBITDA | (19.89 M) | ||||
| Net Income | (22.03 M) | ||||
| Cash And Equivalents | 9.43 M | ||||
| Cash Per Share | 0.88 X | ||||
| Total Debt | 5.12 M | ||||
| Debt To Equity | 1.12 % | ||||
| Current Ratio | 1.32 X | ||||
| Book Value Per Share | 0.11 X | ||||
| Cash Flow From Operations | (12.88 M) | ||||
| Short Ratio | 4.15 X | ||||
| Earnings Per Share | (2.55) X | ||||
| Price To Earnings To Growth | (0.13) X | ||||
| Target Price | 3.1 | ||||
| Number Of Employees | 47 | ||||
| Beta | 0.37 | ||||
| Market Capitalization | 1.08 M | ||||
| Total Asset | 25.91 M | ||||
| Retained Earnings | (68.62 M) | ||||
| Working Capital | 13.21 M | ||||
| Current Asset | 18.53 M | ||||
| Current Liabilities | 5.32 M | ||||
| Z Score | -2.8 | ||||
| Net Asset | 25.91 M |
About Viveve Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Viveve Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Viveve Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Viveve Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Viveve Pink Sheet
If you are still planning to invest in Viveve Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Viveve Medical's history and understand the potential risks before investing.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |